Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
Photo: Illustration: Lazaro Gamio/Axios
Raising venture capital for a "vice" product used to be almost impossible, due to specific restrictions in limited partnership agreements. And many of those anti-vice clauses persist, even with the mainstreaming of cannabis.
The big picture: Dockery's big pitch is that the relative lack of competition — and of federal legalization, in the case of cannabis — means that many valuations are artificially depressed. The fund already has invested in a handful of startups, including Recess (CBD-infused drink), Indose (cannabis vaporizer), and Bev (canned rosé wine).
There's an entire fund devoted to the cause:
- Vice Ventures is led by Catharine Dockery, a former Walmart digital brands executive who before that led private investments for Bonobos founder Andy Dunn.
- Target sectors include cannabis, alcohol, sextech and gambling.
- It just raised $25 million for its debut fund, all from individual investors (including Marc Andreessen and Bradley Tusk).
- Dockery says it was difficult to get family offices to invest, often due to conservative older family members.
Dockery also said few other niche areas of interest:
- Psychedelics: Vice won't fund clinical trial-stage companies ("I'm not a doctor"), instead waiting until products hit market.
- Esports: "They're highly addictive."
- Tobacco: "We'll be investing in harm reduction products."